Candel Therapeutics CADL
NASDAQ CADL
$10.81 -0.07 (-0.64%)
As of: Sep 30, 2026 · 12:34 PM EDT

Candel Therapeutics, Inc. (CADL) Payables (2020 - 2026)

Updated

Candel Therapeutics (CADL) posted Payables of $5.15 million for Q2 2026, up 163.9% from $1.95 million a year earlier.

Analysis

Candel Therapeutics, Inc. (CADL) Payables (2020 - 2026) Analysis & Trends

At the end of FY2025, Candel Therapeutics' Payables came in at $1.13 million, up 376.4% from FY2024.

  • Annual Payables shows a five-year compound annual growth rate of 4.2% (FY2020 to FY2025).
  • In prior years, Candel Therapeutics' Payables was $237,000 in FY2024 (-43.8%), $422,000 in FY2023 (+11.1%), $380,000 in FY2022 (-76.1%) and $1.59 million in FY2021 (+72.6%).
  • The Q2 2026 figure stands as the highest quarterly Payables in data going back to Q4 2020.
  • On a year-over-year basis, Payables increased in six of the last seven quarters, with growth averaging 172.1%.
  • The strongest year-over-year quarter for Payables in the past five years was Q4 2025, with growth of 376.4%; the weakest was Q4 2022, with a decline of 76.1%.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.15 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 1.12 Mn
Jun 30, 2025 1.95 Mn
Mar 31, 2025 760,000.00
Dec 31, 2024 237,000.00
Sep 30, 2024 296,000.00
Jun 30, 2024 433,000.00
Mar 31, 2024 472,000.00
Dec 31, 2023 422,000.00
Sep 30, 2023 250,000.00
Jun 30, 2023 480,000.00
Mar 31, 2023 592,000.00
Dec 31, 2022 380,000.00
Sep 30, 2022 970,000.00
Jun 30, 2022 1.58 Mn
Mar 31, 2022 1.39 Mn
Dec 31, 2021 1.59 Mn
Sep 30, 2021 925,000.00
Jun 30, 2021 759,000.00
API Access

Candel Therapeutics, Inc. Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=CADL&period=max&api_key=YOUR_API_KEY